Title | Geography | Industry | ||||
---|---|---|---|---|---|---|
Number of ongoing Clinical Trials (for drugs) involving Recurrent Medulloblastoma by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Sezary Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Uveal Melanoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Anaplastic Astrocytoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hairy Cell Leukemia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Merkel Cell Carcinoma by Phase | Other Industry Indicators | Hungary | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Astrocytoma by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Lung Cancer by Phase | Other Industry Indicators | Bosnia and Herzegovina | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Gliosarcoma by Phase | Other Industry Indicators | Hong Kong | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Follicular Lymphoma by Phase | Other Industry Indicators | Luxembourg | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Squamous Cell Carcinoma by Phase | Other Industry Indicators | Romania | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pheochromocytoma by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Thymic Carcinoma by Phase | Other Industry Indicators | Hungary | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Prostate Cancer by Phase | Other Industry Indicators | Colombia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Ependymoma by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Skin Cancer by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Meningioma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Chordoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Ocular Melanoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Chondrosarcoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Craniopharyngioma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Polycythemia Vera by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Medulloblastoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Non-Small Cell Lung Cancer by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Myelofibrosis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Mycosis Fungoides by Phase | Other Industry Indicators | Belgium | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Leukemia by Phase | Other Industry Indicators | Romania | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Solid Tumor by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Mantle Cell Lymphoma by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Low-Grade Glioma by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Adenocarcinoma by Phase | Other Industry Indicators | Ukraine | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Oligodendroglioma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Renal Cell Carcinoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | - | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Metastatic Prostate Cancer by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Retinoblastoma by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Osteosarcoma by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Diffuse Large B-Cell Lymphoma by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Oncology by Phase | Other Industry Indicators | Hungary | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Melanoma by Phase | Other Industry Indicators | Switzerland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Glioma by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Leiomyosarcoma by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Metastatic Melanoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Ewing Sarcoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Myelodysplastic Syndrome by Phase | Other Industry Indicators | Switzerland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Rhabdomyosarcoma by Phase | Other Industry Indicators | Poland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Soft Tissue Sarcoma by Phase | Other Industry Indicators | South Korea | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Small-Cell Lung Cancer by Phase | Other Industry Indicators | Israel | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Synovial Sarcoma by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer